24.95MMarket Cap
LossP/E TTM
BioXcel Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of BioXcel Therapeutics Inc is 5.84, ranking 141 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -0.17, which is -98.11% below the recent high of -0.00 and -52899.76% above the recent low of -89.89.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.